Profil
John W.
Dorbin served as Counsel at CTS Corp.
from 2005 to 2012.
He then worked as Vice President & General Counsel at Supreme Industries, Inc. from 2012 to 2018.
In 2020, he joined Arcimoto, Inc. as Secretary & General Counsel, a position he held until 2023.
Currently, he is serving as Secretary & General Counsel at DMK Pharmaceuticals Corp.
Mr. Dorbin holds a graduate degree from the University of Notre Dame and an undergraduate degree from Purdue University.
Anciens postes connus de John Dorbin
| Sociétés | Poste | Fin |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Conseiller Juridique Général | 27/06/2024 |
| ARCIMOTO, INC. | Conseiller Juridique Général | 19/10/2023 |
| SUPREME INDUSTRIES, INC. | Conseiller Juridique Général | 01/08/2018 |
| CTS CORPORATION | Corporate Officer/Principal | 01/02/2012 |
Formation de John Dorbin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
CTS Corp.
CTS Corp. Electronic Production EquipmentElectronic Technology Designs, manufactures and sells sensors, connectivity components and actuators to the transportation, industrial and medical markets | Electronic Technology |
Supreme Industries, Inc.
Supreme Industries, Inc. Motor VehiclesConsumer Durables Designs and manufactures industrial trucks | Consumer Durables |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcimoto, Inc.
Arcimoto, Inc. Motor VehiclesConsumer Durables Manufactures electric vehicles, bolts and provides fleet rental services | Consumer Durables |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DMK Pharmaceuticals Corp.
DMK Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of opioid overdose and substance-use disorders | Health Technology |
















